7651 - 7700 of 7785 Results
Title
Year
-
RESTRICTEDTitle: Funding of Parkinson research from industry and US federal and foundation sourcesJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 5Start Page: 731End Page: 737Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22446Best OA location URL: http://ecommons.library.cornell.edu/bitstream/1813/15097/2/Nicholson 09 pub 02.pdfCitation Count: 6
-
RESTRICTEDTitle: Future of cell and gene therapies for Parkinson's diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 64Issue #: S2Start Page: S122End Page: S138Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.21473Best OA location URL: https://europepmc.org/articles/pmc3982797?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: Alzheimer Research Forum Live Discussion: Mice on Trial? Issues in the Design of Drug StudiesJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 16Issue #: 1Start Page: 197End Page: 205Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-2009-0961Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad00961?id=journal-of-alzheimers-disease%2Fjad00961Citation Count: 1
- Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammation2009RESTRICTEDTitle: Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 215Issue #: 1Start Page: 5End Page: 19Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2008.09.003Best OA location URL: https://europepmc.org/articles/pmc2765462?pdf=renderCitation Count: 223
-
RESTRICTEDTitle: Differentiation of Neural Precursors and Dopaminergic Neurons from Human Embryonic Stem CellsJournal Name: Methods in Molecular BiologyPublisher: Humana PressVol:Issue #:Start Page: 355End Page: 366Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/978-1-60761-369-5_19Best OA location URL: https://europepmc.org/articles/pmc2948208?pdf=renderCitation Count: 93
- Linkage of cDNA expression profiles of mesencephalic dopaminergic neurons to a genome-wide in situ hybridization database2009RESTRICTEDTitle: Linkage of cDNA expression profiles of mesencephalic dopaminergic neurons to a genome-wide in situ hybridization databaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page: 6End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/1750-1326-4-6Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/1750-1326-4-6Citation Count: 7
- The Role of Lmx1a in the Differentiation of Human Embryonic Stem Cells into Midbrain Dopamine Neurons in Culture and After Transplantation into a Parkinson's Disease Model2009RESTRICTEDTitle: The Role of Lmx1a in the Differentiation of Human Embryonic Stem Cells into Midbrain Dopamine Neurons in Culture and After Transplantation into a Parkinson's Disease ModelJournal Name: Stem CellsPublisher: Oxford University Press (OUP)Vol: 27Issue #: 1Start Page: 220End Page: 229Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1634/stemcells.2008-0734Best OA location URL: https://academic.oup.com/stmcls/article-pdf/27/1/220/41946326/stmcls_27_1_220.pdfCitation Count: 76
- Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease2008RESTRICTEDTitle: Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1172/jci36470Best OA location URL: http://www.jci.org/articles/view/36470/files/pdfCitation Count: 905
-
RESTRICTEDTitle: Promise of mGluR2/3 activators in psychiatryJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 34Issue #: 1Start Page: 248End Page: 249Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/npp.2008.156Best OA location URL: https://www.nature.com/articles/npp2008156.pdfCitation Count: 37
- JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degeneration2008RESTRICTEDTitle: JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degenerationJournal Name: Journal of NeurochemistryPublisher: WileyVol: 107Issue #: 6Start Page: 1578End Page: 1588Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05713.xBest OA location URL: https://europepmc.org/articles/pmc2632584?pdf=renderCitation Count: 77
-
RESTRICTEDTitle: Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicityJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/1756-6606-1-17Best OA location URL: https://molecularbrain.biomedcentral.com/counter/pdf/10.1186/1756-6606-1-17Citation Count: 232
-
RESTRICTEDTitle: The Unified Dyskinesia Rating Scale: Presentation and clinimetric profileJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 16Start Page: 2398End Page: 2403Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22341Citation Count: 212
- Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studies2008RESTRICTEDTitle: Structural insights into phenylethanolamines high-affinity binding site in NR2B from binding and molecular modeling studiesJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 1Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/1756-6606-1-16Best OA location URL: https://molecularbrain.biomedcentral.com/counter/pdf/10.1186/1756-6606-1-16Citation Count: 17
-
RESTRICTEDTitle: Ephrin‐A5 regulates the formation of the ascending midbrain dopaminergic pathwaysJournal Name: Developmental NeurobiologyPublisher: WileyVol: 69Issue #: 1Start Page: 36End Page: 46Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/dneu.20685Best OA location URL: https://europepmc.org/articles/pmc4026181?pdf=renderCitation Count: 39
-
RESTRICTEDTitle: Olfactory bulb α-synucleinopathy has high specificity and sensitivity for Lewy body disordersJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 117Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-008-0450-7Best OA location URL: https://europepmc.org/articles/pmc2631085?pdf=renderCitation Count: 197
-
RESTRICTEDTitle: Stem cells in development of therapeutics for Parkinson's disease: A perspectiveJournal Name: Journal of Cellular BiochemistryPublisher: WileyVol: 105Issue #: 5Start Page: 1153End Page: 1160Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/jcb.21916Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jcb.21916Citation Count: 15
-
RESTRICTEDTitle: Genetic variation of Omi/HtrA2 and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 14Issue #: 7Start Page: 539End Page: 543Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2008.08.003Best OA location URL: https://europepmc.org/articles/pmc2614082?pdf=renderCitation Count: 67
- The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors2008RESTRICTEDTitle: The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviorsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 32Issue #: 2Start Page: 229End Page: 242Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2008.06.018Best OA location URL: https://europepmc.org/articles/pmc2886670?pdf=renderCitation Count: 60
-
RESTRICTEDTitle: Administration and Scoring Variance on the ADAS-CogJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 15Issue #: 3Start Page: 461End Page: 464Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-2008-15312Best OA location URL: https://europepmc.org/articles/pmc2727511?pdf=renderCitation Count: 67
-
RESTRICTEDTitle: Dietary Iron Intake and Risk of Parkinson's DiseaseJournal Name: American Journal of EpidemiologyPublisher: Oxford University Press (OUP)Vol: 168Issue #: 12Start Page: 1381End Page: 1388Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/aje/kwn273Best OA location URL: https://academic.oup.com/aje/article-pdf/168/12/1381/365552/kwn273.pdfCitation Count: 83
- Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulators2008RESTRICTEDTitle: Positive allosteric modulators of the metabotropic glutamate receptor subtype 4 (mGluR4): Part I. Discovery of pyrazolo[3,4-d]pyrimidines as novel mGluR4 positive allosteric modulatorsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 18Issue #: 20Start Page: 5626End Page: 5630Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2008.08.087Best OA location URL: https://europepmc.org/articles/pmc3182458?pdf=renderCitation Count: 53
- Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative disease2008RESTRICTEDTitle: Proteomic identification of proteins in the human brain: Towards a more comprehensive understanding of neurodegenerative diseaseJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 2Issue #: 10-11Start Page: 1484End Page: 1497Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/prca.200800043Best OA location URL: https://europepmc.org/articles/pmc3142616?pdf=renderCitation Count: 26
-
RESTRICTEDTitle: Proteomics of Human Neurodegenerative DiseasesJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 67Issue #: 10Start Page: 923End Page: 932Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/nen.0b013e318187a832Best OA location URL: https://academic.oup.com/jnen/article-pdf/67/10/923/9557140/67-10-923.pdfCitation Count: 35
- Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trial2008RESTRICTEDTitle: Cost effectiveness of preventing falls and improving mobility in people with Parkinson disease: protocol for an economic evaluation alongside a clinical trialJournal Name: BMC GeriatricsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/1471-2318-8-23Best OA location URL: https://bmcgeriatr.biomedcentral.com/track/pdf/10.1186/1471-2318-8-23Citation Count: 25
-
RESTRICTEDTitle: Activation of recombinant NR1/NR2C NMDA receptorsJournal Name: The Journal of PhysiologyPublisher: WileyVol: 586Issue #: 18Start Page: 4425End Page: 4439Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1113/jphysiol.2008.158634Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1113/jphysiol.2008.158634Citation Count: 104
- Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease2008RESTRICTEDTitle: Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson diseaseJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 118Issue #: 9Start Page: 3087End Page: 3097Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1172/jci35781Best OA location URL: http://www.jci.org/articles/view/35781/files/pdfCitation Count: 183
- Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian rats2008RESTRICTEDTitle: Intranigral Lentiviral Delivery of Dominant-negative TNF Attenuates Neurodegeneration and Behavioral Deficits in Hemiparkinsonian ratsJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 16Issue #: 9Start Page: 1572End Page: 1579Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/mt.2008.146Best OA location URL: http://www.cell.com/article/S1525001616320548/pdfCitation Count: 110
-
RESTRICTEDTitle: Enantiomeric Propanolamines as selectiveN-Methyl-d-aspartate 2B Receptor AntagonistsJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 51Issue #: 18Start Page: 5506End Page: 5521Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/jm8002153Best OA location URL: https://europepmc.org/articles/pmc3142473?pdf=renderCitation Count: 24
-
RESTRICTEDTitle: Generation of Stable Transgenic C. elegans Using MicroinjectionJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 18Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/833Best OA location URL: https://europepmc.org/articles/pmc3253564?pdf=renderCitation Count: 66
-
RESTRICTEDTitle: A Genome‐wide Scan in an Amish Pedigree with ParkinsonismJournal Name: Annals of Human GeneticsPublisher: WileyVol: 72Issue #: 5Start Page: 621End Page: 629Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1469-1809.2008.00452.xBest OA location URL: https://europepmc.org/articles/pmc2764120?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synucleinJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 105Issue #: 31Start Page: 10907End Page: 10912Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1073/pnas.0802437105Best OA location URL: https://www.pnas.org/content/pnas/105/31/10907.full.pdfCitation Count: 236
-
RESTRICTEDTitle: UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicalsJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 454Issue #: 7206Start Page: 846End Page: 851Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nature07181Best OA location URL: https://europepmc.org/articles/pmc4101536?pdf=renderCitation Count: 665
- Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 42008RESTRICTEDTitle: Discovery, Characterization, and Antiparkinsonian Effect of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 4Journal Name: Molecular PharmacologyPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 74Issue #: 5Start Page: 1345End Page: 1358Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/mol.108.049551Best OA location URL: https://europepmc.org/articles/pmc2574552?pdf=renderCitation Count: 177
-
RESTRICTEDTitle: Neuronal gene expression correlates of Parkinson's disease with dementiaJournal Name: Movement DisordersPublisher: WileyVol: 23Issue #: 11Start Page: 1588End Page: 1595Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22184Best OA location URL: https://europepmc.org/articles/pmc2666445?pdf=renderCitation Count: 47
- Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease Genes2008RESTRICTEDTitle: Application of a C. elegans Dopamine Neuron Degeneration Assay for the Validation of Potential Parkinson's Disease GenesJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/835Best OA location URL: https://europepmc.org/articles/pmc3253614?pdf=renderCitation Count: 33
-
RESTRICTEDTitle: Evaluation of α-synuclein immunohistochemical methods used by invited expertsJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 116Issue #: 3Start Page: 277End Page: 288Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00401-008-0409-8Best OA location URL: https://europepmc.org/articles/pmc2708176?pdf=renderCitation Count: 160
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study2008RESTRICTEDTitle: Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 7Issue #: 7Start Page: 583End Page: 590Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/s1474-4422(08)70117-0Best OA location URL: http://www.thelancet.com/article/S1474442208701170/pdfCitation Count: 1344
-
RESTRICTEDTitle: Strengths and limitations of genetic mouse models of Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 14Issue #:Start Page: S84End Page: S87Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2008.04.004Best OA location URL: https://europepmc.org/articles/pmc2577895?pdf=renderCitation Count: 74
-
RESTRICTEDTitle: Value of genetic models in understanding the cause and mechanisms of Parkinson’s diseaseJournal Name: Current Neurology and Neuroscience ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 4Start Page: 288End Page: 296Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11910-008-0045-7Best OA location URL: https://europepmc.org/articles/pmc4431569?pdf=renderCitation Count: 42
-
RESTRICTEDTitle: Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisJournal Name: Annals of NeurologyPublisher: WileyVol: 64Issue #: 1Start Page: 60End Page: 70Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.21425Best OA location URL: https://europepmc.org/articles/pmc2674108?pdf=renderCitation Count: 654
- Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP Biosensor2008RESTRICTEDTitle: Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP BiosensorJournal Name: Molecular PharmacologyPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 74Issue #: 3Start Page: 585End Page: 594Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/mol.108.048884Best OA location URL: https://europepmc.org/articles/pmc3766527?pdf=renderCitation Count: 140
- Morphometric analysis of hypothalamic cells showing c-Fos proteins after movement restriction and EHF-irradiation2008RESTRICTEDTitle: Morphometric analysis of hypothalamic cells showing c-Fos proteins after movement restriction and EHF-irradiationJournal Name: PathophysiologyPublisher: Elsevier BVVol: 15Issue #: 1Start Page: 19End Page: 24Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pathophys.2007.11.001Citation Count: 6
-
RESTRICTEDTitle: Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonismJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 30Issue #: 3Start Page: 430End Page: 438Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2008.02.011Best OA location URL: https://europepmc.org/articles/pmc2605654?pdf=renderCitation Count: 61
- Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease2008RESTRICTEDTitle: Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 131Issue #: 7Start Page: 1880End Page: 1894Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awn101Best OA location URL: https://academic.oup.com/brain/article-pdf/131/7/1880/1093630/awn101.pdfCitation Count: 307
-
RESTRICTEDTitle: Changes in attack behavior and activity in EphA5 knockout miceJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1205Issue #:Start Page: 91End Page: 99Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2008.02.047Best OA location URL: https://europepmc.org/articles/pmc4042433?pdf=renderCitation Count: 22
-
RESTRICTEDTitle: CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson DiseasesJournal Name: American Journal of Clinical PathologyPublisher: Oxford University Press (OUP)Vol: 129Issue #: 4Start Page: 526End Page: 529Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1309/w01y0b808emeh12lBest OA location URL: https://academic.oup.com/ajcp/article-pdf/129/4/526/24985935/ajcpath129-0526.pdfCitation Count: 246
-
RESTRICTEDTitle: Therapeutic cloning in individual parkinsonian miceJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 14Issue #: 4Start Page: 379End Page: 381Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/nm1732Best OA location URL: https://europepmc.org/articles/pmc2786166?pdf=renderCitation Count: 114
-
RESTRICTEDTitle: Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s DiseasesJournal Name: Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 14Issue #: 7-8Start Page: 451End Page: 464Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.2119/2007-00100.irvineBest OA location URL: https://molmed.biomedcentral.com/counter/pdf/10.2119/2007-00100.IrvineCitation Count: 469
- The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–20072008RESTRICTEDTitle: The Sun Health Research Institute Brain Donation Program: Description and Eexperience, 1987–2007Journal Name: Cell and Tissue BankingPublisher: Springer Science and Business Media LLCVol: 9Issue #: 3Start Page: 229End Page: 245Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s10561-008-9067-2Best OA location URL: https://link.springer.com/content/pdf/10.1007/s10561-008-9067-2.pdfCitation Count: 233
- Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's disease2008RESTRICTEDTitle: Allosteric modulation of mGluR4 as a novel therapeutic direction for the treatment of Parkinson's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 22Issue #: S1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fasebj.22.1_supplement.103.2Citation Count: 0